Sun Pharma's US arm launches anticancer injection

NEW DELHI: Sun Pharmaceutical's US arm Caraco has launched oxaliplatin injections, used in the treatment of cancer, in the American market.

These oxaliplatin injections have been introduced in 50mg and 100mg strength after approval from US Food and Drug Administration, Caraco said in a statement.

Oxaliplatin is an anticancer used in the treatment of colon and rectal cancer. These injections have annual sales of about USD 1.3 billion in America.

Detroit-based Caraco Pharmaceutical Laboratories Ltd develops, manufactures, markets generic drugs to wholesalers, distributors and drugstore chains.